Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

An innovation in glaucoma surgery: XEN45 gel stent implantation

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Glaucoma and Imaging

Venue: Poster Village: Pod 3

First Author: : O.Kaplaner TURKEY

Co Author(s): :    B. Bayar   S. Alzal           

Abstract Details

Purpose:

To report the follow-up data after XEN45 gel stent implantation which is a new method of ninimal invasive glaucoma surgery (MIGS)

Setting:

Uzunköprü State Hospital, Trakya University Hospital

Methods:

Fifteen eyes of fifteen patients which had XEN45 gel stent implantation surgery were enrolled the study. All patients were examined at preoperative, 1 day, 1 and 2 week, and 1,2,3,6 and 12 months. Intraocular pressure (IOP) was measured by Goldmann applanation tonometry. Combined surgery (XEN 45 + phacoemulsification +intraocular lens) were performed in the cases which have cataract in addition to glaucoma.

Results:

Mean IOP values significantly decreased at all of the visits when compared to preoperative value (p<0.001). In 2 cases IOP values were above 20 mmHg at the postoperative 12 month. These IOP increases controlled by medical therapy and none of the patients required another surgical procedure.

Conclusions:

XEN45 gel stent implantation is a MIGS that ensures effectively reducing of IOP. This new treatment modality also provides avoiding destructive complications encountered in the other invasive surgical procedures. However, we need more studies which have greater number of patients and longer follow-up period to clarify the unknown points on this issue.

Financial Disclosure:

NONE

Back to previous